SCHEMBL5658273

SCHEMBL5658273

COC(=O)c1cc(OC)c(OC)c(O)c1Br

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
POLB P06746 2/20 0.57
USP2 O75604 1/20 0.53
HSD17B10 Q99714 1/20 0.53
PTPN1 P18031 1/20 0.50
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 1/20 0.44
MCL1 Q07820 1/20 0.43
GAA P10253 1/20 0.43
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
TSHR P16473 2/20 0.42
APOBEC3A P31941 1/20 0.41
HTT P42858 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27671945 0.86 KDM4E (0.51) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL21635979 0.86 KDM4E (0.65) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL9576652 0.84 KDM4E (0.67) KDM4EPOLBUSP2HSD17B10MAPT
SCHEMBL3979015 0.80 KDM4E (0.57) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL2113203 0.80 KDM4E (0.53) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL644549 0.79 KDM4E (0.56) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL27371099 0.78 KDM4E (0.47) KDM4EPOLBUSP2HSD17B10PTPN1
SCHEMBL5658267 0.78 KDM4E (0.54) KDM4EPOLBUSP2HSD17B10MAPT
SCHEMBL1434290 0.77 MAPT (0.71) KDM4EPOLBUSP2HSD17B10MAPT
SCHEMBL438401 0.76 KDM4E (0.53) KDM4EPOLBUSP2HSD17B10PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR KDM4E 1540/4885POLB 731/4885USP2 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.